Karim Helmy, MD, Ph.D Vice President
Image
United States New York
Karim Helmy, MD, Ph.D Vice President

Karim Helmy is a Vice President at General Atlantic and focuses on life sciences investments in the firm’s global Healthcare sector. Before joining General Atlantic in 2019, Karim was a Vice President at Venrock where he lead all aspects of venture investing in early stage biotech. Prior to that, he was an Engagement Manager at McKinsey & Company. Karim was also previously a Research Associate at Genentech.


Historical Board Affiliations

Corvidia Therapeutics, Board Member

Education

Stanford University, B.S., Biology
Memorial Sloan Kettering Cancer Center, Ph.D
New Jersey Medical School, MD
Columbia University / New York Presbyterian Medical Center, Internal Medicine Residency